Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions
Since 2011, use of immune checkpoint inhibitors (ICI) in cancer immunotherapy dramatically expanded, both alone and in combination with either a different cancer treatment or with two different ICIs. With this increase in use have come a myriad of adverse effects from enhanced immune activation, inc...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2022-11-01
|
| Sarja: | Frontiers in Ophthalmology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fopht.2022.1044904/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|